Associated Papers
Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin.
Zhou G et al.
Frontiers in Physiology, 2014
SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes.
Zhou G et al.
Surgery, 2011
Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegaly.
Ciganoka D et al.
European Journal of Endocrinology, 2011
The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function.
Zhou G et al.
World Journal of Surgery, 2011
Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival.
Li D et al.
Cancer, 2011
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly.
Filopanti M et al.
The Journal of Clinical Endocrinology and Metabolism, 2005
Analysis of transmission of novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene in patients with autism.
Lauritsen MB et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2003
Novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene associated with bipolar affective disorder.
Nyegaard M et al.
Molecular Psychiatry, 2002
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment.
Ballarè E et al.
The Journal of Clinical Endocrinology and Metabolism, 2001
Select a paper to view details